Trimtech Therapeutics closed a £35.6 million seed round, also reported as €41 million. The funding will support development of its therapeutic platform. The round was led by a syndicate of investors focused on early-stage biotech.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Houdini Bio secures £1.5m to improve gene and cell therapies